IMO, all IMMD has to do is confirm their revenue. As of their previous releases:
03/06/2017 "ImmuDyne’s top line revenue grew from $714,000 in 2014 to $1,250,000 in 2015 and is expected to be reported at over $5,000,000 in 2016."
04/17/2017 " ...no material adjustments, restatement or other revisions to previously issued financial statements of the Company are currently expected to be required."
I'm invested in IMMD. Yes, I want it to do well. I strive to project my positivism as much as I can, without being redundant.
True, I am new to investing in penny stocks, hoping for big return. No need for baseless accusations. New account only means new investor. I'm also invested in THCBF, and also, I want it to do well (about time)
You can still get in cheap, but you have missed a very short bottom @ 0.38. Bashing IMMD will not work at this point.
GLTY & GLTA
$$$$ IMMD $$$$
